Acute Otitis Media — Why "Always Prescribe Antibiotics" Is No Longer the Standard

Audience
Parents of children 6 months–6 years
Target length
~1,500 words
Status
Draft v1 (translated from Japanese v1)
Original
../234_acute_otitis_media.md

Lead

"Ear infection means antibiotics" — this near-universal assumption changed significantly after the American Academy of Pediatrics (AAP) revised its clinical practice guideline in 2013 [1]. The update formally incorporated "watchful waiting" as a recommended option in defined circumstances, establishing that immediate antibiotic treatment is not always required. Japan's clinical practice guideline, revised in 2018, reflects the same shift [5]. Why did the guidance change, and what does it mean in practice?


How Common Is Acute Otitis Media, and What Causes It?

Acute otitis media is one of the most common bacterial infections in young children — by age three, 60–70% of children will have had at least one episode [1]. The usual mechanism is bacteria that colonize the nasopharynx (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) reaching the middle ear through the Eustachian tube following a viral respiratory infection. A proportion of cases are caused by virus alone.

Known risk factors include daycare attendance, passive smoke exposure, and feeding an infant with a bottle while lying flat [1]. The widespread adoption of the pneumococcal conjugate vaccine (PCV13/PCV15) has reduced the incidence of pneumococcal otitis media.


What Is Watchful Waiting?

The central message of the 2013 AAP guideline is that not every case of acute otitis media requires immediate antibiotics [1].

Immediate antibiotic treatment is recommended when:

Watchful waiting (48–72 hours of observation) is an option when:

When watchful waiting is chosen, antibiotics are started if symptoms worsen or do not improve within 48–72 hours. This approach assumes the parent and clinician have discussed and agreed on the plan.

The randomized controlled trials that underpinned this guideline change showed that 60–80% of children over age two with mild otitis media recover without antibiotics [2,3].


When Antibiotics Are Indicated

Amoxicillin is the first-choice antibiotic when treatment is indicated. Antibiotic-resistant strains have increased in many countries, and the AAP guideline recommends high-dose amoxicillin (40–90 mg/kg/day) [1]. Duration of treatment is generally five to ten days depending on severity and age.

A Finnish placebo-controlled randomized trial (Tähtinen 2011) found that the number needed to treat (NNT) with antibiotics to achieve one additional treatment success was 8 [2]. This is not negligible — "8 children treated to benefit one" describes real, meaningful efficacy in the right clinical context. The same trial also found that diarrhea and other adverse effects occurred at roughly twice the rate in the antibiotic group compared with placebo [2]. It is this balance that informs the watchful-waiting approach for milder cases.


Resistance and Recurrent Otitis Media

The increase in penicillin-resistant S. pneumoniae (PRSP) is a concern in many countries and is the reason high-dose amoxicillin is preferred. If this fails, amoxicillin-clavulanate is a next-line option.

Children who experience three or more episodes within six months, or four or more within a year, may be candidates for insertion [4]. This surgical procedure maintains ventilation of the middle ear and reduces recurrence frequency.


Translating Evidence into Everyday Decisions


Summary

The management of acute otitis media has moved from "ear infection equals antibiotics" to "a decision shaped by the specifics." The shift is grounded in evidence that many mild cases resolve without treatment and in concern about antibiotic side effects and rising resistance. Watchful waiting is not "doing nothing" — it is an active, structured period of observation with a clear plan for escalation, agreed upon between the clinician and the family.


References

  1. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964–e999. doi:10.1542/peds.2012-3488. PMID: 23439909.
  2. Tähtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med. 2011;364(2):116–126. doi:10.1056/NEJMoa1007174. PMID: 21226577.
  3. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364(2):105–115. doi:10.1056/NEJMoa0912254. PMID: 21226576.
  4. Rosenfeld RM, Schwartz SR, Pynnonen MA, et al. Clinical practice guideline: tympanostomy tubes in children. Otolaryngol Head Neck Surg. 2013;149(1 Suppl):S1–S35. doi:10.1177/0194599813487302. PMID: 23818543.
  5. Japanese Society of Otology; Japanese Society for Pediatric Ear, Nose and Throat. Clinical Practice Guideline for Pediatric Acute Otitis Media, 2018 edition. Tokyo: Kanehara Shuppan; 2018.